Pharmaceutical Industry
By Jeffrey Sonnenfeld, Stephen Henriques, Ferron Chen, Asuka Koda and Vanessa McLennanFebruary 11, 2026
By Paul HudsonFebruary 10, 2026
By Jessica Nix, Madison Muller and BloombergFebruary 7, 2026
By Ruth UmohFebruary 2, 2026
SuccessPfizer CEO Albert Bourla’s best leadership advice: Being optimistic is better than being right
By Preston ForeJanuary 31, 2026
C-Suite‘We’ll save the world from cancer’: Inside Pfizer CEO’s $23 billion post‑COVID bet on oncology
By Nick LichtenbergJanuary 30, 2026
HealthAs billionaires chase immortality, this startup cofounded by a Harvard genetics professor gets FDA approval for the first partial de-aging human trial
By Marco Quiroz-GutierrezJanuary 30, 2026
Workplace CultureWalmart doubles down on health, promoting 3,000 pharmacy workers and upping earning potential—with no college degree required
By Sydney LakeJanuary 29, 2026
C-SuitePfizer CEO on how he struck a deal with President Trump in 10 days to lower American drug costs
By Fortune EditorsJanuary 27, 2026
InvestingInside Big Pharma and VC’s big bet on AI: You wouldn’t ‘want to fly an airplane designed by hand, but all of our drugs are designed like that’
By Nick LichtenbergJanuary 23, 2026
AIAI drug startup Insilico Medicine launches an AI ‘gym’ to help models like GPT and Qwen be good at science
By Nicholas GordonJanuary 22, 2026
EconomyTrump says Europe does one thing right: drug prices. ‘A pill that costs $10 in London costs $130 in New York or Los Angeles’
By Sasha RogelbergJanuary 21, 2026
AIAnthropic unveils Claude for Healthcare, expands life science features, and partners with HealthEx to let users connect medical records
By Jeremy KahnJanuary 11, 2026
Most Popular
